Keystone Symposia Board of Directors

Keystone Symposia is governed by a volunteer Board of Directors composed of distinguished scientists from academia, industry, government and foundations. The board meets three times each year to provide guidance and direction to Keystone Symposia staff, and to participate with the larger Scientific Advisory Board in the determination of future conference topics and organizers. Members serve 3-year terms, and up to 3 consecutive terms. New board members are identified and recruited by the Nominating Committee of the Board, and elected by the full Board.


Gary J. Nabel, M.D., Ph.D.
Chair of the Board
Chief Scientific Officer
Research and Development
Sanofi

Walter H. Moos, Ph.D.
Treasurer of the Board, Chair-Finance Committee
CEO, ShangPharma Innovation Inc.
Professor (adj.), University of California, San Francisco
President (ret.), SRI Biosciences

E. Dale Abel, M.D., Ph.D.
Chair-Personnel Committee
Director F.O.E. Diabetes Research Center
Professor of Medicine and Biochemistry
University of Iowa, Carver College of Medicine

CheriƩ L. Butts, Ph.D.
Associate Director
Portfolio Leadership
Biogen

Robert Califf, M.D., MACC
Donald F. Martin, MD Professor of Cardiology
Duke University, Verily Life Sciences
School of Medicine

Vishva M. Dixit, M.D.
Chair-Development Committee
Vice President, Early Discovery Research and Physiological Chemistry
Genentech, Inc.

Peter M. Finan, Ph.D.
Governance Coordinator, Chair-Audit Committee
Venture Partner
Epidarex Capital

Geoffrey S. Ginsburg, M.D., Ph.D.
Director
The Duke Center for Applied Genomics & Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.
Chair of the Scientific Advisory Board
Professor, Pediatrics
Director of Stem Cells & Regenerative Medicine Center
Baylor College of Medicine

Anthony R. Hunter, Ph.D.
Professor and Principal Investigator
Molecular Cellular Biology Laboratories
The Salk Institute for Biological Sciences

Thale C. Jarvis, Ph.D.
Chief Scientific Officer
Keystone Symposia

Juan Carlos Lopez, Ph.D.
Founder
Haystack Science

Anne O'Garra, Ph.D., FRS, FMedSci
Associate Research Director
The Francis Crick Institute
Mill Hill Laboratory

Jane L. Peterson, Ph.D.
President and Chief Executive Officer
Keystone Symposia

Bei B. Zhang, Ph.D.
Vice President, Metabolic Research
Worldwide Research and Development
Internal Medicine
Pfizer Inc.

Juleen R. Zierath, Ph.D.
Chair-Nominating Committee
Professor
Department of Molecular Medicine and Surgery
Karolinska Institutet


Emeritus Board Members:

Ralph A. Bradshaw, Ph.D.
Emeritus Board Member
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Edward A. Dennis, Ph.D.
Emeritus Board Member
Professor
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Curtis C. Harris, M.D.
Emeritus Board Member
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health